Tirellizumab Combined With TP Neoadjuvant Therapy in the Treatment of Early Oral Squamous Cell Carcinoma （HNC-SYSU-005）
Clinical trial NCT07267286 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07267286
- Sponsor
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-15
- Primary completion
- 2028-08-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.